Textbooks

Alan H. DeCherney; Lauren Nathan; Neri Laufer; Ashley S. Roman


... In an effort to create a universally accepted system of nomenclature to describe uterine bleeding abnormalities in reproductive-age women, an alternative classification system was published in 2011 by the International Federation of Gynecology and Obstetrics (FIGO) ( Fig. 39–1 ) and adopted...
View in context

... Table 46–3. Main or serious adverse events of antibiotics commonly used in obstetric-gynecologic practice and pregnancy risk categories. Antibiotic Main or Serious Adverse Events FDA Pregnancy Categories 1 β-Lactams (penicillins, cephalosporins, carbapenems...
View in context

... Table 46–4. Recommended and alternative antimicrobial drugs against selected bacteria encountered in obstetric-gynecologic practice. Suspected or Proved Etiologic Agent Recommended Drug(s) Alternative Drug(s) Gram-negative cocci     Neisseria...
View in context

... Table 46–5. Treatment regimens for selected infections in obstetric-gynecologic practice. Clinical Diagnosis Etiologies Recommended Regimen Alternative Regimen/Comments Chancroid Haemophilus ducreyi Ceftriaxone 250 mg IM single dose...
View in context

... Table 47–5. Cardiac conditions for which prophylaxis for obstetric-gynecologic procedures associated with infection or dental procedures is reasonable. Cardiac Condition Prosthetic cardiac valve or prosthetic material used for cardiac repair Previous infective...
View in context

... Table 49–1. International Federation of Gynecology and Obstetrics (FIGO) staging of vulvar cancer. TNM Category FIGO Stage Definition Primary tumor size (T) Tis 0 Carcinoma in situ, intraepithelial carcinoma T1a IA Tumor confined...
View in context

... Table 49–2. International Federation of Gynecology and Obstetrics (FIGO) staging of carcinoma of the vagina. Preinvasive carcinoma Stage 0 Carcinoma in situ, intraepithelial carcinoma Invasive carcinoma Stage I The carcinoma is limited...
View in context